Aehr Test (AEHR)
NASDAQ:AEHR
Want to see AEHR full AI Analyst Report?
AEHR Stock Chart & Stats
$83.86
-$1.97(-11.05%)
At close: 4:00 PM EST
$83.86
-$1.97(-11.05%)
Day’s Range― - ―
52-Week Range$10.89 - $126.62
Previous CloseN/A
Volume811.84K
Average Volume (3M)2.29M
Market Cap
$3.63B
Enterprise Value$3.52B
Total Cash (Recent Filing)$36.91M
Total Debt (Recent Filing)$10.03M
Price to Earnings (P/E)―
Beta2.53
Next Earnings
Jul 21, 2026EPS Estimate
>-0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.38
Shares Outstanding31,453,255
10 Day Avg. Volume1,819,233
30 Day Avg. Volume2,287,045
Financial Highlights & Ratios
PEG Ratio0.66
Price to Book (P/B)2.30
Price to Sales (P/S)4.79
P/FCF Ratio-22.77
Enterprise Value/Market Cap0.97
Enterprise Value/Revenue77.68
Enterprise Value/Gross Profit252.83
Enterprise Value/Ebitda-302.92
Forecast
1Y Price Target
$62.00Price Target Upside-26.07% Downside
Rating ConsensusStrong Buy
Number of Analyst Covering3
EPS Forecast (FY)0.15
Revenue Forecast (FY)$85.11M
Bulls Say, Bears Say
Bulls Say
Record Bookings And BacklogA multi-month record in bookings and a >3.5x book-to-bill with a $50.9M effective backlog indicates a durable revenue pipeline. Large production orders increase visibility for equipment shipments and reduce short-term demand dependence, supporting a multi-quarter revenue recovery if conversions proceed.
Growing Consumables Recurring RevenueA shift toward ~30%+ consumables revenue creates a higher-margin, repeatable revenue stream tied to installed base growth. Recurring consumables reduce top-line cyclicality from capital equipment sales, support steadier gross margins, and improve long-term cash generation as deployments scale.
Completed $60M ATM Equity OfferingCompleting the $60M ATM raises the company’s capital buffer and financial flexibility during a production ramp. This liquidity supports inventory, contract manufacturer scale-up, and R&D without immediate debt pressure, extending the runway for bookings-to-ship conversion and margin improvement.
Bears Say
Recent Revenue And Profit DeteriorationMaterial declines in revenue and a swing to deeply negative margins indicate weakened earnings power and heightened cyclicality. Sustained losses impair return on capital and can delay reinvestment, making multi-quarter recovery dependent on timely shipment conversion and margin normalization.
Negative Operating Cash Flow And Cash BurnPersistent negative operating and free cash flow reduces internal funding for growth and increases reliance on external capital. Continued cash burn elevates execution risk if bookings slip, forcing dilutive raises or curtailed investment, which can undermine long-term margin and capacity expansion plans.
Lumpy Orders And Technical Evaluation DelaysLarge, irregular orders and protracted technical benchmarks make revenue timing unpredictable and hinder steady capacity utilization. This variability complicates operations, creates uneven margin realization across periods, and raises the chance that backlog will convert slower than planned.
Aehr Test Systems News
AEHR FAQ
What was Aehr Test’s price range in the past 12 months?
Aehr Test lowest stock price was $10.89 and its highest was $126.62 in the past 12 months.
What is Aehr Test’s market cap?
Aehr Test’s market cap is $3.63B.
When is Aehr Test’s upcoming earnings report date?
Aehr Test’s upcoming earnings report date is Jul 21, 2026 which is in 30 days.
How were Aehr Test’s earnings last quarter?
Aehr Test released its earnings results on Apr 07, 2026. The company reported -$0.05 earnings per share for the quarter, beating the consensus estimate of -$0.07 by $0.02.
Is Aehr Test overvalued?
According to Wall Street analysts Aehr Test’s price is currently Overvalued.
Does Aehr Test pay dividends?
Aehr Test does not currently pay dividends.
What is Aehr Test’s EPS estimate?
Aehr Test’s EPS estimate is >-0.01.
How many shares outstanding does Aehr Test have?
Aehr Test has 31,453,255 shares outstanding.
What happened to Aehr Test’s price movement after its last earnings report?
Aehr Test reported an EPS of -$0.05 in its last earnings report, beating expectations of -$0.07. Following the earnings report the stock price went up 25.692%.
Which hedge fund is a major shareholder of Aehr Test?
Currently, no hedge funds are holding shares in AEHR
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Aehr Test Systems Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$62.00 (-26.07% Downside)
$62.00 (-26.07% Downside)
Blogger Sentiment
Bullish
AEHR Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 160.6K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $41.1M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 2.3%
Last 30 Days ▲ 9.9%
Last 30 Days ▲ 9.9%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
901.73%
12-Months-Change
Fundamentals
Return on Equity
-8.87%
Trailing 12-Months
Asset Growth
7.86%
Trailing 12-Months
Company Description
Aehr Test
Aehr Test Systems, founded in 1977 and based in Fremont, California, specializes in the global provision of advanced burn-in and test systems for integrated circuits, encompassing logic, optical, and memory devices. Its extensive product lineup includes the ABTS and FOX-P families of test and burn-in solutions, complemented by specialized components such as the FOX WaferPak Aligner, FOX-XP WaferPak Contactor, FOX DiePak Carrier, and FOX DiePak Loader. The ABTS system is specifically designed for both production and qualification assessments of packaged parts, covering a range of lower and higher power logic devices, as well as various memory types. For more complex integrated circuits like memories, digital signal processors, microprocessors, microcontrollers, systems-on-a-chip, and integrated optical devices, the FOX-XP and FOX-NP systems facilitate burn-in and functional testing at both the wafer and individual die/module levels. Aehr's FOX-CP system offers a compact, single-wafer solution for verifying the reliability of logic, memory, and photonic devices. A distinguishing offering, the WaferPak Contactor, features an exclusive full-wafer probe card, accommodating wafers up to 300mm, which enables semiconductor manufacturers to conduct comprehensive wafer-level testing and burn-in on Aehr's FOX platforms. Furthermore, the DiePak Carrier provides a reusable, temporary packaging medium, empowering IC manufacturers to complete final testing and burn-in processes for bare die and modules.
AEHR Earnings Call
Q3 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presented a mix of strong commercial momentum and near-term financial softness. Positive takeaways include a dramatic bookings surge (Q3 $37.2M vs $6.2M in Q2), a record effective backlog ($50.9M), multiple large customer wins across wafer-level AI, silicon photonics, package-level hyperscaler production, and expanded manufacturing capacity (>20 Sonoma/month). These items underpin management's guidance for fiscal '26 revenue to be on the high side of prior guidance and a return to non-GAAP profitability in Q4. Offsetting these positives are a sizable YOY revenue decline (-44% to $10.3M), gross margin contraction (-6.2 percentage points), a non-GAAP net loss in the quarter versus prior-year profit, lumpy timing of large orders, and some technical delays in benchmark evaluations. Overall, the forward-looking bookings, backlog and customer engagements are substantial and suggest meaningful future growth potential, while near-term operational and margin pressures create short-term risk.View all AEHR earnings summariesAEHR Stock 12 Month Forecast
Average Price Target
$62.00
▼(-26.07% Downside)
Technical Analysis
Ownership Overview
5.39% Insiders
20.66% Mutual Funds
24.65% Other Institutional Investors
36.30% Public Companies and Individual Investors